Flu Campaigns Bug FDA

When Roche Laboratories launched the second phase of its Tamiflu consumer campaign earlier this month, it had a captive audience. The flu, which has sent thousands of sufferers to hospital emergency rooms throughout the country, is one of the winter season's most debilitating conditions. Although the drug is being recognized as a new flu weapon, the FDA issued an advisory this month that cautions consumers that the latest flu treatments are not cures.